AJMC February 25, 2022
Advancing Precision Medicine Through Comprehensive Genomic Profiling (CGP) – Episode 11
Bruce Feinberg, DO: Before we get to billing, whether it was 50, 150, or 500 genes, if the costs were the same, are there other issues with the number tested from a payer perspective?
Eugean Jiwanmall, MPH, MBA: I’ll give a simple answer. Kenna is going to like this. Kenna, I hear you, maybe there’s some variation in how your institution is billing or who’s is responsible for paying for it. Let me answer Bruce’s part.
Bruce, this is what I was talking about from my evolution perspective of how things have changed from Sanger…sequencing—small panels, big panels, we have to deal with it. When it comes to procedure...
Today's Sponsors
Today's Sponsor